4//SEC Filing
Doyle Mittie 4
Accession 0001578563-25-000026
CIK 0001534120other
Filed
Jan 29, 7:00 PM ET
Accepted
Jan 30, 5:20 PM ET
Size
5.6 KB
Accession
0001578563-25-000026
Insider Transaction Report
Form 4
Doyle Mittie
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-01-28+155,000→ 155,000 totalExercise: $8.04Exp: 2035-01-28→ Common Stock (155,000 underlying)
Footnotes (1)
- [F1]The stock option vests twenty-five percent (25%) on January 28, 2026 and the remainder will vest in equal monthly installments over the following three (3) years, subject to the Reporting Person's continued service on such vesting date.
Documents
Issuer
Avalo Therapeutics, Inc.
CIK 0001534120
Entity typeother
Related Parties
1- filerCIK 0001918845
Filing Metadata
- Form type
- 4
- Filed
- Jan 29, 7:00 PM ET
- Accepted
- Jan 30, 5:20 PM ET
- Size
- 5.6 KB